Inc., a clinical-stage biotechnology company focused on developing innovative therapies for retinal diseases with significant unmet needs, announced today that it has entered into an option agreement ...

Across all DME patients dosed to date, 4D-150 continues to be well tolerated with no intraocular inflammation observed at any timepoint or dose ...

Character Biosciences, a pioneer in genetics-guided drug discovery and development, today announced a collaboration with Bausch + Lomb, a leading global eye health company, to develop innovative ...

The first bucket is the simple and stylish glasses. The more stylish and comfortable smart glasses are, the fewer features ...

The following is a summary of “Microcystoid macular edema in epiretinal membrane: not a retrograde maculopathy,” published in ...

City Therapeutics, Inc., a privately held biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, today announced that it has entered into a strategic collaboration ...

City Therapeutics has inked a new deal with Bausch + Lomb for a gene silencing approach to the eye disorder geographic ...

This isn’t something you’re just buying for today — it should be something that helps your practice grow over the years.

Soliddd, an optical and vision technology company, will debut the beta headset version of its virtual reality smart glasses ...

“Brighter irises and larger pupils elicited greater donations,” noted experts from the Netherlands’ Leiden University in a ...

Some megatrends in health care are occurring that deserve our attention. We already know that as much as one-third of the U.S ...

Omega-3 polyunsaturated fatty acids and docosahexaenoic acid appear to be associated with lower age-related macular ...